Wednesday, December 4, 2024
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
PRESENTING FACULTY
 |
Seong H. Cho, MD Professor of Medicine Division of Allergy-Immunology Department of Internal Medicine Morsani College of Medicine University of South Florida Tampa, FL |
PROGRAM OVERVIEW
This program will focus on reviewing patient-specific factors and clinical presentations to improve the diagnosis of chronic rhinosinusitis with nasal polyps (CRSwNP). Risk-to-benefit ratio, and treatment guidelines will be explored to determine the appropriate use of biologics in the treatment of CRSwNP. The importance of a multidisciplinary team approach to develop personalized treatment plans for patients with CRSwNP will also be addressed.
TARGET AUDIENCE
This activity is designed to meet the educational needs of community primary care physicians and advanced practice providers, as well as other members of the multidisciplinary care team, such as otolaryngologists, ENT specialists, pulmonologists, and allergists involved in the diagnosis, treatment, and follow-up of patients with CRSwNP.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Interpret clinical presentation and patient-specific factors to improve the diagnosis of or specialty referral for the diagnosis of CRSwNP
- Describe the scientific rationale, benefit and risk profiles, and evidence-based treatment guideline recommendations for the use of biologics to treat CRSwNP
- Utilize multidisciplinary team (MDT) and shared decision making (SDM) approaches to develop personalized treatment plans for patients with CRSwNP
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
